INSM

Insmed (INSM)

Insmed Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INSM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/13	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
2024/06/13	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/06/07	21 : 00	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
2024/06/06	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/06/05	21 : 00	PR Newswire (US)	Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
2024/06/04	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
2024/06/04	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	06 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
2024/05/31	05 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/31	05 : 05	PR Newswire (US)	Insmed to Host Commercial Webinar on June 4, 2024	NASDAQ:INSM	Insmed Inc
2024/05/31	05 : 02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:INSM	Insmed Inc
2024/05/30	21 : 00	PR Newswire (US)	Insmed Announces Pricing of $650 Million Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
2024/05/29	07 : 21	PR Newswire (US)	Insmed Announces Proposed $500 Million Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/29	05 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
2024/05/28	19 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
2024/05/28	19 : 30	PR Newswire (US)	Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc
2024/05/28	19 : 30	PR Newswire (US)	Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc
2024/05/28	05 : 00	PR Newswire (US)	Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc
2024/05/21	05 : 28	PR Newswire (US)	Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Confe	NASDAQ:INSM	Insmed Inc
2024/05/18	05 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc